Built on the regulations that protect patients
Our name comes from Title 21 of the Code of Federal Regulations, and it reflects a commitment that has guided us since 2001: patient safety, regulatory compliance, and operational excellence.
As the field evolved, so did we. Title21 grew beyond compliance to serve cellular therapy labs, blood and marrow transplant programs, and biotherapeutic manufacturers, while holding to the same mission: simplify complex processes, improve quality, and enable vital work.
Today, we connect the full advanced therapy workflow, bringing quality, manufacturing, clinical, and operational planning into one digital suite that reduces risk, raises efficiency, and speeds therapies to patients.
Two decades of growth, one direction
From quality management to a connected suite for advanced therapies, each step has brought us closer to the work our customers do every day.
- 2001
Founded
Title21 starts with a focus on quality management in FDA-regulated health sciences.
- Growth
Into cell therapy
The company expands to serve cellular therapy labs, blood and marrow transplant programs, and biotherapeutic manufacturers.
- 2026
MyCellHub
Acquiring MyCellHub adds a manufacturing execution system for advanced therapies, with real-time production monitoring and digital batch records.
- 2026
cResults
Acquiring cResults adds two decades of quality operations planning and scheduling, plus regulatory intelligence and AI-powered document review.
- Today
One digital suite
Quality, manufacturing, clinical, and operational planning come together to speed the delivery of therapies to patients.
Our Mission
Biotherapies are the future of medicine. We design software that links clinical practice, laboratory science, and therapeutic manufacturing, so our customers can serve patients with quality, efficiency, and kindness.
The industry needs higher quality and better access to tools and data to find and deliver cures. We take pride in supporting our customers’ workflows and in collecting and presenting the data they need to share their stories and care for their patients.
100+
Healthcare sites
12+ years
Of cell therapy expertise
2001
Founded in quality management for FDA-regulated health sciences
Two solutions. One record from start to finish.
GxP Solutions run the regulated work of collecting, manufacturing, and releasing a therapy. Business Solutions plan the lab and quality work around it. Compliant AI works across both, from batch record review to regulatory risk.
● GxP Solutions
Validated systems for collection, manufacturing, and quality.
● Business Solutions
AI-assisted tools that shorten review, testing, and regulatory work.
Built for 21 CFR Part 11 and ALCOA+ data integrity
Our leadership
The team guiding Title21’s product, technology, clinical, and people strategy.
Join our team of innovators
We are a community of problem-solvers and collaborators bringing innovative software to patients worldwide. If you want to use your talents to make a real impact, explore our open positions and find a career where your contributions matter.
North America
2325 E. Camelback Rd., Suite 320Phoenix, AZ 85016, USA
866.848.5321
Europe
Kempische Steenweg 303/2003500 Hasselt, Belgium
VAT BE 0729.548.579
Help us shape what comes next.
Whether you are delivering therapies today or scaling for tomorrow,
we would like to hear what your teams need.







